Scarica l'app Stockscreener
0.5701
0.02%
0.0001
Dopo l'orario di chiusura:
.57
-0.0001
-0.02%
Precedente Chiudi:
$0.57
Aprire:
$0.53
Volume 24 ore:
53,602
Relative Volume:
12.25
Capitalizzazione di mercato:
$N/A
Reddito:
$18.10M
Utile/perdita netta:
$-16.56M
Rapporto P/E:
-0.5963
EPS:
-0.9561
Flusso di cassa netto:
$-7.45M
1 W Prestazione:
+111.15%
1M Prestazione:
+104.04%
6M Prestazione:
-57.46%
1 anno Prestazione:
+3.84%
Intervallo 1D:
$0.53
$0.575
Intervallo di 1 settimana:
$0.521
$0.575
Portata 52W:
$0.2564
$1.3402
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI vs UNH, CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRAI
Marpai Inc
|
0.5701 | 0 | 18.10M | -16.56M | -7.45M | -0.9561 |
UNH
Unitedhealth Group Inc
|
408.52 | 368.30B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
101.96 | 128.21B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
404.07 | 86.69B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
298.00 | 77.99B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
379.22 | 44.27B | 137.20B | 1.15B | 1.27B | 9.3439 |
Marpai Inc Borsa (MRAI) Ultime notizie
Dallas Scrip Net Worth (2026) - GuruFocus
Marpai CFO Steve Johnson buys $682 in stock, granted award By Investing.com - Investing.com India
[Form 4] Marpai, Inc. Insider Trading Activity - Stock Titan
Marpai CFO Steve Johnson buys $682 in stock, granted award - Investing.com
Marpai (MRAI) director receives 175,000-share grant and forfeits 50,000 RSUs - Stock Titan
Marpai (MRAI) director reports 125,000-share RSU grant and 50,000 RSU forfeiture - Stock Titan
Marpai (MRAI) director reports 100K RSU grant and 484K shares - Stock Titan
Marpai (MRAI) director gets 100,000-share RSU grant, forfeits 50,000 - Stock Titan
Marpai (MRAI) director DiClaudio receives 125,000-share fully vested stock grant - Stock Titan
Marpai secures 192,000 new member lives, projects profitability - Investing.com
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - PR Newswire
Marpai (MRAI) director Eitan Yaron adds 10,000 shares in open-market buy - Stock Titan
MARPAI reports net loss of USD 3.2M in Q1 2026 - Medical Buyer
Marpai reports Q1 2026 results with cloud migration nearing completion and targets profitability in H2 2026 - Pluang
Marpai reports Q1 loss, targets second-half profitability - Investing.com
Marpai reports Q1 loss, targets second-half profitability By Investing.com - Investing.com Nigeria
Marpai (MRAI) Q1 2026 shows losses, heavy debt and going concern risk - Stock Titan
BRIEF-Marpai Q1 Revenue USD 4.4 Million - TradingView
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PR Newswire
Marpai secures major new contracts, boosting path to profitability with integrated healthcare services. - Pluang
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability - The Norfolk Daily News
Marpai Extends Maturity of Insider Promissory Notes - TipRanks
Marpai (MRAI) pushes $660,000 CEO promissory notes out to Sept. 1, 2026 - Stock Titan
Marpai, Inc. (MRAI) - Minichart
Marpai (MRAI) director receives 100,000 RSUs tied to strategic deal - Stock Titan
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide - PR Newswire
Marpai, Inc. Empowers Self-Insured Employers With AI-Driven TPA Services, Cost Savings, and Healthcare Solutions - Minichart
Marpai 2025 10-K: Revenue $18.1M, EPS $(0.95) - TradingView
Marpai, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Marpai Inc. (MRAI) warns of going concern risk and OTCQX trading shift - Stock Titan
Marpai, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Marpai (NASDAQ:MRAI) Stock Price Down 3.9% – Here’s Why - Defense World
Marpai Secures CEO Loan to Bolster Near-Term Liquidity - The Globe and Mail
Marpai enters $250,000 loan agreement with CEO Damien Lamendola - Investing.com India
Marpai, Inc. Files Form 8-K Announcing Promissory Note Dated March 9, 2026 - Minichart
Marpai Raises $250,000 Via 12% Promissory Note From CEO, Maturing May 10, 2026 - TradingView
CEO lends $250K to Marpai (OTCQX: MRAI) in short-term note - Stock Titan
Marpai, Inc. Enters Marketing Agreement To Expand MarpaiRx National Distribution Channel - marketscreener.com
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives - Yahoo Finance
Marpai, Inc. announced that it has received $0.25 million in funding - marketscreener.com
Intelligent Fanatics, Ian Cassel report 4.4% stake in Marpai (MRAI) - Stock Titan
MRAI SEC FilingsMarpai Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Marpai (NASDAQ:MRAI) Shares Up 15.2% – Time to Buy? - defenseworld.net
MRAI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion - ChartMill
Marpai Secures Insider Promissory Note for Working Capital - TipRanks
Marpai Signs Promissory Note With Damien Lamendola - TradingView
Marpai’s Strategic Moves Under Investor Scrutiny - AD HOC NEWS
Marpai, Inc. announced that it has received $0.41 million in funding - marketscreener.com
Marpai hires Mimi Davis as president of MarpaiRx to drive growth - Investing.com Australia
Marpai Inc Azioni (MRAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.47%
3.66%
Capitalizzazione:
|
Volume (24 ore):